Showing results (261-270 of 390) with videos related to

Sort By:
Pageof 39
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Neurofilament light levels are associated with long-term outcomes in multiple sclerosisJens Kuhle, Tatiana Plavina, Christian Barro, et al.
Archives of Neurology|September 10, 2008
Reproducibility of optical coherence tomography in multiple sclerosisDeanna Cettomai, Mathew Pulicken, Eliza Gordon-Lipkin, et al.
Lancet (London, England)|February 11, 2014
EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trialAndrew S C Rice, Robert H Dworkin, Tom D McCarthy, et al.
Multiple Sclerosis and Related Disorders|February 7, 2020
Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QDGary Cutter, Antonella Veneziano, Augusto Grinspan, et al.
The New England Journal of Medicine|February 14, 2024
Inhibition of CD40L with Frexalimab in Multiple SclerosisPatrick Vermersch, Cristina Granziera, Yang Mao-Draayer, et al.
Contemporary Clinical Trials|April 26, 2019
Rationale and design of the STEP for MS Trial: Comparative effectiveness of Supervised versus Telerehabilitation Exercise Programs for Multiple SclerosisRobert W Motl, Deborah Backus, Whitney N Neal, et al.
Multiple Sclerosis and Related Disorders|May 28, 2019
Higher satisfaction and adherence with glatiramer acetate 40 mg/mL TIW vs 20 mg/mL QD in RRMSGary Cutter, Antonella Veneziano, Augusto Grinspan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 12, 2012
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivationSilvia Rossi, Caterina Motta, Valeria Studer, et al.
Hypertension (Dallas, Tex. : 1979)|December 13, 2017
Accuracy of Blood Pressure Measurement Devices in Pregnancy: A Systematic Review of Validation StudiesNatalie A Bello, Jonathan J Woolley, Kirsten Lawrence Cleary, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2025
Comparing the macromolecular-to-free pool size ratio and the magnetization transfer ratio for the assessment of myelin injury in early multiple sclerosisAhmad A Toubasi, Marc Graham, Gary Cutter, et al.
Pageof 39